HUB Investment Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
HUB Investment Partners's BMY Position: Q1 2026 in Review
HUB Investment Partners increased its Bristol-Myers Squibb (BMY) stake by 13% in Q1 2026, buying an estimated $183K and bringing the position to 27,433 shares worth $1.66M. The position accounts for 0.04% of the portfolio, ranked #275.
HUB Investment Partners first reported a position in BMY in Q4 2020 and has held it in 21 quarters since. The position peaked at $2.73M in Q2 2022. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- HUB Investment Partners held 27,433 shares of Bristol-Myers Squibb worth $1.66M as of Q1 2026.
- HUB Investment Partners bought 3,143 Bristol-Myers Squibb shares in Q1 2026, an estimated $183K.
- Bristol-Myers Squibb made up 0.04% of HUB Investment Partners's portfolio in Q1 2026, its #275 holding.
- HUB Investment Partners first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 21 quarters since.
- HUB Investment Partners's Bristol-Myers Squibb position peaked at $2.73M in Q2 2022.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on HUB Investment Partners's 13F filing for Q1 2026, filed 15 May 2026.